Zobrazeno 1 - 10
of 32
pro vyhledávání: '"LUIS ARANGO"'
Publikováno v:
Dyna, Vol 73, Iss 150, Pp 59-66 (2006)
Este trabajo comprende el estudio experimental del efecto conjunto de la inclusión de aditivos (sacarina de sodio y cloruro de amonio), y la utilización de una onda de corriente rectangular, en la dureza de níquel electro-depositado sobre cobre
Externí odkaz:
https://doaj.org/article/6e760c3aa5ee4ae9a266c5cc6009e979
Publikováno v:
Lecturas de Economía, Iss 78 (2013)
Ciclos de negocios en Colombia, 1975-2011 Resumen: Se propone una cronología para los ciclos de negocios de Colombia en la concepción clásica del NBER; esto es, determinando las fechas de picos y valles en la actividad económica sin separar las s
Externí odkaz:
https://doaj.org/article/bcd79ce530dc43d8bc43e7e2b99a5e87
Publikováno v:
Journal of Advertising. :1-18
Publikováno v:
Psychology & Marketing.
Publikováno v:
Psychology & Marketing, 40(6)
Tactile experiences are a pivotal part of consumer behavior and choice. However, very little is known about why consumers esthetically appreciate touching products. The principle of Unity-in-Variety, stating that consumers like to perceive variety bu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40c3b5fd575ac3ffc3188d181bdf83c8
http://resolver.tudelft.nl/uuid:73e633b5-7091-4369-8ba0-d5d3f0658e86
http://resolver.tudelft.nl/uuid:73e633b5-7091-4369-8ba0-d5d3f0658e86
Autor:
Luis Arango, Heikki Karjaluoto, Matias Lievonen, Markus Muhonen, Outi Niininen, Stephen Singaraju, J. Graham Spickett-Jones, Gerrit Sundermann, Chiara Valentini
Publikováno v:
Social Media for Progressive Public Relations ISBN: 9781003177791
Public relations (PR) focuses on storytelling by creating newsworthy content that will be communicated to target audiences. However, because social media has empowered individual consumers to an unprecedented level, we are no longer passive consumers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cdbcb448759702e17c5396804b49de7
http://urn.fi/URN:NBN:fi:jyu-202303142164
http://urn.fi/URN:NBN:fi:jyu-202303142164
Autor:
Michael R. Zile, Marc A. Pfeffer, Lars Lund, John J.V. McMurray, Antonio S. Sibulo, Gerard C.M. Linssen, Lars Køber, Victor Shi, Juan Luis Arango, Dragos Vinereanu, Brian Claggett, Martin Lefkowitz, Milton Packer, Jean L. Rouleau, Michele Senni, Scott D. Solomon, Adel R. Rizkala, Inder S. Anand, Chen Huan Chen, Karl Swedberg, Nancy K. Sweitzer, Muthiah Vaduganathan, Béla Merkely, Sergey Boytsov, Akshay S. Desai
Publikováno v:
Circulation. 141:352-361
Background: While disease-modifying therapies exist for heart failure (HF) with reduced left ventricular ejection fraction (LVEF), few options are available for patients in the higher range of LVEF (>40%). Sacubitril/valsartan has been compared with
Autor:
Joanna Chikwe, Stefan D. Anker, Akshay S. Desai, Muthiah Vaduganathan, Victor Shi, Milton Packer, Scott D. Solomon, Sergio V. Perrone, Brian Claggett, Stefan Janssens, Martin Lefkowitz, Juan Luis Arango, John Mcmurray, Davor Miličić, David H. Adams
Publikováno v:
Journal of the American College of Cardiology. 75:e15-e18
Autor:
Muthiah Vaduganathan, Milton Packer, Akshay S. Desai, Juan Luis Arango, Stefan D. Anker, Martin Lefkowitz, Stefan Janssens, Davor Miličić, Scott D. Solomon, Victor Shi, John J.V. McMurray, Brian Claggett, Sergio V. Perrone
Background The period shortly after hospitalization for heart failure (HF) represents a high-risk window for recurrent clinical events, including rehospitalization or death. Objectives This study sought to determine whether the efficacy and safety of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7927db19707b46070e3f9daef193448
https://acuresearchbank.acu.edu.au/item/8vz69/prior-heart-failure-hospitalization-clinical-outcomes-and-response-to-sacubitril-valsartan-compared-with-valsartan-in-hfpef
https://acuresearchbank.acu.edu.au/item/8vz69/prior-heart-failure-hospitalization-clinical-outcomes-and-response-to-sacubitril-valsartan-compared-with-valsartan-in-hfpef